Item 9 Secures Financing to Expand Lab Sites in Arizona and Nevada


Ryan Allway

August 31st, 2021

News


Pelorus Equity Group (“Pelorus”), the leading provider of value-add bridge commercial real estate loans to cannabis businesses and owners with cannabis-related real estate, has entered into a $19 million construction-financing loan with Item 9 Labs Corp. (OTCQX: INLB) (the “Company”), a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products.

The funds will be utilized to expand the master site development of the Company’s cultivation and lab site in Coolidge, Arizona (the “Arizona Facility”), as well as to finish the Company’s current 20,000 square foot facility in Pahrump, Nevada (the “Nevada Facility”). Since 2017, the Arizona facility has been farming and manufacturing a variety of premium Item 9 Labs cannabis products. Early in 2022, the Nevada Facility will be operating.

The profits from Pelorus’ high-performance loan will be used to purchase 45 acres of land close to the company’s current 19,200 square foot Arizona facility. The 5 acres that hold the existing plant, which includes two steel structures, are now owned by the Company. The master site development includes 16 greenhouses and six headhouses, as well as six additional steel structures (just under 10,000 sq. ft. apiece) – one for lab extension and support space for completed product, and the other five for indoor production – and 16 greenhouses (or greenhouse support buildings). The Item 9 Labs complex will have a total operational area of over 640,000 square feet once completed. This includes 5 acres of outdoor growing, which comes at a good time because the city of Coolidge just enacted outdoor cultivation regulations earlier this year.

Item 9 Labs’ product line includes more than 75 active cannabis strains, over 150 distinct cannabis vape products, premium concentrates, and Orion vaping technology. According to LeafLink, Item 9 Labs is currently the most popular brand at more than 60% of Arizona’s dispensaries. Arizona’s overall legal marijuana market is expected to reach $1.5 billion in the next three years, according to industry analysts.

Construction on Phase 1 will begin in early October and be completed in mid-2022. The first phase of construction includes three steel buildings and two greenhouses. This first extension includes 9,600 square feet of indoor cultivation space, 9,600 square feet of lab and packing space, and a 9,600 square foot head house to accommodate the addition of two 18,000 square foot greenhouses. Item 9 Labs expects to increase premium flower output by 30-35 percent and minimize its need on third-party supplied material for lab outputs by 40-50 percent once the project is completed. Item 9 Labs expects to hire 60-70 individuals in the first phase to support new operations in cultivation, processing, and packaging.

Item 9 Labs will also utilize the funds to finish its 20,000 square foot state-of-the-art facility in Pahrump, Nevada, which is now 60% complete. The new area comprises 4,450 square feet for flower, 990 square feet for plants, 400 square feet for clones, 300 square feet for dry curing, and 615 square feet for genetics. There’s also more than 2,500 square feet of post-processing and lab space, as well as the possibility of a cooperative venture with a 1,100-square-foot commercial kitchen. Auxiliary areas such as water rooms, offices, locker rooms, and break rooms make up the rest of the facility. The Company will cultivate and manufacture for partner dispensaries across the Silver State once it is completed in late 2021.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading